Close

Dr Chu-Chang Ku

Research Fellow in Infectious Disease Modelling

United Kingdom

I joined the School in December 2023. I am a member of the modelling research theme of the NIHR Health Protection Research Unit in Vaccines and Immunisation. My research focuses on the health policy assessment for infectious disease control. I am also interested in modelling health behaviours. Before joining the School, I was a postdoc at Imperial College London. I have a PhD in health economics and decision science from the University of Sheffield.

Affiliations

Department of Infectious Disease Epidemiology and Dynamics
Faculty of Epidemiology and Population Health

Research

Research Area
Mathematical modelling
Bayesian analysis
Economic evaluation
Health economics
Vaccinations
Disease and Health Conditions
Herpesviruses
Tuberculosis
Country
United Kingdom

Selected Publications

The epidemiological effect and cost-effectiveness of expanded age eligibility for recombinant zoster vaccination in England.
KU, C-C; Rosello, A; Walker, J; Pouwels, KB; Baguelin, M; DAVIES, NG; Jit, M;
2026
Vaccine
Estimating Catastrophic Total Costs among TB-Affected Households in Taiwan: Implications for the End TB Strategy in High-Income Settings
Tseng, H-K; Chu, P-W; KU, CC; Liu, K-Y; Yang, S-L; Chiang, C-Y; Chen, B; Lo, H-Y; Yang, C-C; Lu, C; Huang, Y-J; Huang, Y-F; Lin, H-H;
2026
Elsevier BV
Estimating the impact of nutritional transition and ending hunger on tuberculosis in 12 high-burden countries: a model-based scenario analysis.
Wu, C-Y; KU, C-C; MCQUAID, CF; Lönnroth, K; Cegielski, JP; Bentham, J; Ezzati, M; Lin, H-H;
2025
BMJ global health
Health-related quality of life with herpes zoster: systematic review and analysis of individual patient data from 9 cohorts
KU, C-C; Rosello, A; Hobbelen, P; Pouwels, KB; Breuer, J; Gater, A; Johnson, KD; Van Wijck, AJ M; Drolet, M; Carroll, S; Brisson, M; Baguelin, M; Andrews, N; Van Hoek, AJ; DAVIES, NG; Jit, M;
2025
openRxiv
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
Harnan, S; Kearns, B; Scope, A; Schmitt, L; Jankovic, D; Hamilton, J; Srivastava, T; Hill, H; KU, CC; Ren, S; Rothery, C; Bojke, L; Sculpher, M; Woods, B;
2024
Health technology assessment (Winchester, England)
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
Woods, B; Schmitt, L; Jankovic, D; Kearns, B; Scope, A; Ren, S; Srivastava, T; KU, CC; Hamilton, J; Rothery, C; Bojke, L; Sculpher, M; Harnan, S;
2024
Health technology assessment (Winchester, England)
How many patients are managed by the private healthcare sector? An approach using drug sales data
KU, C-C; Kirankumar, R; Raghuram, R; Nimalan, A;
2023
the Union World Conference on Lung Health
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis.
Reid, M; Agbassi, YJ P; Arinaminpathy, N; Bercasio, A; Bhargava, A; Bhargava, M; Bloom, A; Cattamanchi, A; Chaisson, R; Chin, D; Churchyard, G; Cox, H; Denkinger, CM; Ditiu, L; Dowdy, D; Dybul, M; Fauci, A; Fedaku, E; Gidado, M; Harrington, M; Hauser, J; Heitkamp, P; Herbert, N; Herna Sari, A; Hopewell, P; ... Goosby, E.
2023
Lancet (London, England)
Transmission modeling to infer tuberculosis incidence prevalence and mortality in settings with generalized HIV epidemics.
Dodd, PJ; Shaweno, D; KU, C-C; Glaziou, P; Pretorius, C; HAYES, RJ; MacPherson, P; Cohen, T; AYLES, H;
2023
Nature communications
Accuracy of computer-aided chest X-ray in community-based tuberculosis screening: Lessons from the 2016 Kenya National Tuberculosis Prevalence Survey.
Mungai, B; Ong'angò, J; KU, CC; Henrion, MY R; Morton, B; Joekes, E; Onyango, E; Kiplimo, R; Kirathe, D; Masini, E; Sitienei, J; Manduku, V; Mugi, B; Squire, SB; MacPherson, P; IMPALA Consortium,;
2022
PLOS global public health
See more information